Insights into yeast response to chemotherapeutic agent through time series genome-scale metabolic models
| dc.authorid | 0000-0002-0517-5227 | |
| dc.contributor.author | Karabekmez, Muhammed E. | |
| dc.date.accessioned | 2025-05-10T19:53:34Z | |
| dc.date.issued | 2024 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description.abstract | Organism-specific genome-scale metabolic models (GSMMs) can unveil molecular mechanisms within cells and are commonly used in diverse applications, from synthetic biology, biotechnology, and systems biology to metabolic engineering. There are limited studies incorporating time-series transcriptomics in GSMM simulations. Yeast is an easy-to-manipulate model organism for tumor research. Here, a novel approach (TS-GSMM) was proposed to integrate time-series transcriptomics with GSMMs to narrow down the feasible solution space of all possible flux distributions and attain time-series flux samples. The flux samples were clustered using machine learning techniques, and the clusters' functional analysis was performed using reaction set enrichment analysis. A time series transcriptomics response of Yeast cells to a chemotherapeutic reagent-doxorubicin-was mapped onto a Yeast GSMM. Eleven flux clusters were obtained with our approach, and pathway dynamics were displayed. Induction of fluxes related to bicarbonate formation and transport, ergosterol and spermidine transport, and ATP production were captured. Integrating time-series transcriptomics data with GSMMs is a promising approach to reveal pathway dynamics without any kinetic modeling and detects pathways that cannot be identified through transcriptomics-only analysis. The codes are available at . | |
| dc.description.sponsorship | The author kindly express his gratitude to Prof. Dr. Mehmet Guray Guler, Furkan Canturk and Merve Yarc for helpful discussions on technical details. | |
| dc.identifier.doi | 10.1002/bit.28833 | |
| dc.identifier.endpage | 3359 | |
| dc.identifier.issn | 0006-3592 | |
| dc.identifier.issn | 1097-0290 | |
| dc.identifier.issue | 10 | |
| dc.identifier.pmid | 39199017 | |
| dc.identifier.scopus | 2-s2.0-85202587167 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 3351 | |
| dc.identifier.uri | https://doi.org/10.1002/bit.28833 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/12776 | |
| dc.identifier.volume | 121 | |
| dc.identifier.wos | WOS:001299555400001 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.institutionauthor | Karabekmez, Muhammed E. | |
| dc.language.iso | en | |
| dc.publisher | Wiley | |
| dc.relation.ispartof | Biotechnology and Bioengineering | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WOS_20250302 | |
| dc.subject | doxorubicin | |
| dc.subject | genome scale metabolic models | |
| dc.subject | time series transcriptomics | |
| dc.subject | yeast | |
| dc.title | Insights into yeast response to chemotherapeutic agent through time series genome-scale metabolic models | |
| dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1










